chartexchange

SLN
Silence Therapeutics Plc
stockNASDAQADR

Market OpenNov 19, 2026 3:05:44 PM EST
19.82USD-0.025%(-0.00)93,084
Pre-marketNov 19, 2026 8:00:30 AM EST
19.87USD+0.252%(+0.05)
19.81Bid19.82Ask0.01Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
London, UK, United Kingdom
Previous Close
$19.82
Beta
1.53
52-Week High
$19.87 2026-10-26
52-Week Low
$4.19 2026-02-12
SMA 50
$15.02
SMA 200
$10.00
Avg. Vol 10D
940,693
Avg. Vol 30D
4.20M
Avg. Vol 90D
2.19M
Relative Vol
0.02
37.67M
2.4700%
3,600,000
SLN Profile

silence therapeutics develops a new generation of medicines by harnessing the body's natural mechanism of rna interference, or rnai, within its cells. our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic rna molecules exclusively to target cells. silence's proprietary rna chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases. for more information, visit us at www.silence-therapeutics.com

SLN Performance
PeriodPriceDateChangeBeta
1W19.802026-11-12+0.08%0.175
1M19.582026-10-19+1.20%0.079
3M13.612026-08-19+45.59%1.394
6M5.772026-05-19+243.42%1.658
1Y6.432025-11-19+208.17%1.534
2Y6.972024-11-19+184.29%—
5Y22.952021-11-19-13.66%0.762
SLN Stock Summary

Silence Therapeutics Plc (NASDAQ:SLN) stock price today is $19.82, and today's volume is 86,547. SLN is down 0.025% today. The 30 day average volume is 4.20M. SLN market cap is $1.23B with 62.20M shares outstanding.